RÉSUMÉ
β1,3-galactose is the component of outer-chain elongation of complex N-glycans that, together with α1,4-fucose, forms Lewis a structures in plants. Previous studies have revealed that N-glycan maturation is mediated by sequential attachment of β1,3-galactose and α1,4-fucose by individual β1,3-galactosyltransferase (GalT) and α1,4-fucosyltransferase (1,4-FucT), respectively. Although GalT from several species has been studied, little information about GalT from rice is available. I therefore characterized three GalT candidate genes on different chromosomes in Oryza sativa. Seeds of rice lines that had T-DNA insertions in regions corresponding to individual putative GalT genes were obtained from a Rice Functional Genomic Express Database and plants grown until maturity. Homozygotes were selected from the next generation by genotyping PCR, and used for callus induction. Callus extracts of two independent T-DNA mutant rice which have T-DNA insertions at the same gene on chromosome 6 but in different exons showed highly reduced band intensity on a western blots using an anti-Lewis a antibody. Cell extracts and cultured media from suspension culture of the one of these mutant rice were further analysed by N-glycan profiling using matrix-associated laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF). Identified N-glycan species containing β1,3-galactose from both cell extracts and cultured media of knock-out mutant were less than 0.5% of total N-glycans while that of WT cells were 9.8% and 49.1%, respectively. This suggests that GalT located on rice chromosome 6 plays a major role in N-glycan galactosylation, and mutations within it lead to blockage of Lewis a epitope formation.
Sujet(s)
Rayonnement non ionisantNucléotides adényliques , 5643 , Maladies des bovins , Acide formimino-glutamiqueNucléotides adényliques , 6801 , Rayonnement non ionisantNucléotides adényliques , Chromatographie sur agarose , Perception de la forme , 11134Nucléotides adényliquesRÉSUMÉ
In order to improve the separation process of affinity chromatography that has silica as the main carrier material, we sought to construct Lipid Rafts@CNBr-Sepharose 4B affinity chromatography model. We extracted the lipid rafts from U251 cells with a descaler method and sucrose density gradient centrifugation. Afterwards, it was discovered via immunofluorescence that the lipid rafts contain a large amount of tropomyosin-related kinase A (TrkA) protein. Also, agarose powder in the lyophilised state was pretreated, before the lipid rafts were coupled to the agarose gel in a coupling buffer of alkaline pH. CNBr-Sepharose 4B affinity gel packing was characterised using UV spectrophotometric, immunofluorescence and scanning electron microscopic techniques, wherein and the results showed that the lipid rafts were successfully coupled to the agarose gels. Three compounds were used to verify the specific sorption of Sepharose 4B and CNBr-Sepharose 4B, which showed no specific sorption on the materials. Of note, the prepared Lipid Rafts@CNBr-Sepharose 4B agarose gels packed with TrkA-rich target proteins could be successfully validated for the active drug gefitinib with high affinity sorption efficiency and eluted with good recovery and reproducibility. This study broadens the range of affinity chromatography carrier materials and provides a reference for research in active drug screening.
Sujet(s)
Microdomaines membranaires , Tropomyosine , Agarose , Reproductibilité des résultats , Chromatographie d'affinité/méthodes , Gels , Chromatographie sur agaroseRÉSUMÉ
The prevalence of oral squamous cell carcinoma (OSCC) is high in South and Southeast Asia regions. Most OSCC patients are detected at advanced stages low 5-year survival rates. Aberrant expression of glycosylated proteins was found to be associated with malignant transformation and cancer progression. Hence, identification of cancer-associated glycoproteins could be used as potential biomarkers that are beneficial for diagnosis or clinical management of patients. This study aims to identify the differentially expressed glycoproteins using lectin-based glycoproteomics approaches. Serum samples of 40 patients with OSCC, 10 patients with oral potentially malignant disorder (OPMD), and 10 healthy individuals as control group were subjected to two-dimensional gel electrophoresis (2-DE) coupled with lectin Concanavalin A and Jacalin that specifically bind to N- and O-glycosylated proteins, respectively. Five differentially expressed N- and O-glycoproteins with various potential glycosylation sites were identified, namely N-glycosylated α1-antitrypsin (AAT), α2-HS-glycoprotein (AHSG), apolipoprotein A-I (APOA1), and haptoglobin (HP); as well as O-glycosylated AHSG and clusterin (CLU). Among them, AAT and APOA1 were further validated using enzyme-linked immunosorbent assay (ELISA) (n = 120). It was found that AAT and APOA1 are significantly upregulated in OSCC and these glycoproteins are independent risk factors of OSCC. The clinical utility of AAT and APOA1 as potential biomarkers of OSCC is needed for further evaluation.
Sujet(s)
Marqueurs biologiques tumoraux/sang , Carcinome épidermoïde/sang , Glycoprotéines/sang , Tumeurs de la bouche/sang , Adulte , Sujet âgé , Apolipoprotéine A-I/sang , Apolipoprotéine A-I/métabolisme , Études cas-témoins , Chromatographie d'affinité/méthodes , Chromatographie sur agarose/méthodes , Concanavaline A , Test ELISA , Femelle , Glycoprotéines/métabolisme , Glycosylation , Humains , Mâle , Spectrométrie de masse , Adulte d'âge moyen , Lectines végétales/métabolisme , États précancéreux/sang , Carcinome épidermoïde de la tête et du cou , alpha-1-Antitrypsine/sang , alpha-1-Antitrypsine/métabolismeSujet(s)
Angiotensine-II/sang , Angiotensine-I/sang , COVID-19/physiopathologie , Test ELISA , Fragments peptidiques/sang , SARS-CoV-2 , Chromatographie sur agarose , Humains , Dosage radioimmunologique , Normes de référence , Système rénine-angiotensine/physiologie , Sensibilité et spécificité , Manipulation d'échantillonsRÉSUMÉ
Directed evolution of Cp*RhIII -linked nitrobindin (NB), a biohybrid catalyst, was performed based on an inâ vitro screening approach. A key aspect of this effort was the establishment of a high-throughput screening (HTS) platform that involves an affinity purification step employing a starch-agarose resin for a maltose binding protein (MBP) tag. The HTS platform enables efficient preparation of the purified MBP-tagged biohybrid catalysts in a 96-well format and eliminates background influence of the host E. coli cells. Three rounds of directed evolution and screening of more than 4000 clones yielded a Cp*RhIII -linked NB(T98H/L100K/K127E) variant with a 4.9-fold enhanced activity for the cycloaddition of acetophenone oximes with alkynes. It is confirmed that this HTS platform for directed evolution provides an efficient strategy for generating highly active biohybrid catalysts incorporating a synthetic metal cofactor.
Sujet(s)
Chromatographie d'affinité/méthodes , Chromatographie sur agarose/méthodes , Tests de criblage à haut débit/méthodes , Protéines de liaison au maltose/métabolisme , Composés organométalliques/métabolisme , Composés du ruthénium/métabolisme , Amidon/composition chimique , Catalyse , Composés organométalliques/composition chimique , Composés du ruthénium/composition chimiqueRÉSUMÉ
Amyloid-ß (Aß) peptide and tau protein are two hallmark proteins in Alzheimer's disease (AD); however, the parameters, which mediate the abnormal aggregation of Aß and tau, have not been fully discovered. Here, we have provided an optimum method to purify tau protein isoform 1N4R by using nickel-nitrilotriacetic acid agarose chromatography under denaturing condition. The biochemical and biophysical properties of the purified protein were further characterized using in vitro tau filament assembly, tubulin polymerization assay, circular dichroism (CD) spectroscopy and atomic force microscopy. Afterwards, we investigated the effect of tau protein on aggregation of Aß (25-35) peptide using microscopic imaging and cell viability assay. Incubation of tau at physiologic and supra-physiologic concentrations with Aß25-35 for 40 days under reducing and non-reducing conditions revealed formation of two types of aggregates with distinct morphologies and dimensions. In non-reducing condition, the co-incubated sample showed granular aggregates, while in reducing condition, they formed annular protofibrils. Results from cell viability assay revealed the increased cell viability for the co-incubated sample. Therefore, the disassembling action shown by tau protein on Aß25-35 suggests the possibility that tau may have a protective role in preventing Aß peptide from acquiring the cytotoxic, aggregated form against oxidative stress damages.
Sujet(s)
Maladie d'Alzheimer/métabolisme , Peptides bêta-amyloïdes/métabolisme , Fragments peptidiques/métabolisme , Protéines tau/métabolisme , Maladie d'Alzheimer/anatomopathologie , Peptides bêta-amyloïdes/composition chimique , Survie cellulaire , Chromatographie sur agarose/méthodes , Dichroïsme circulaire/méthodes , Humains , Microscopie à force atomique , Acide nitrilo-triacétique/métabolisme , Stress oxydatif , Fragments peptidiques/composition chimique , Agrégats de protéines , Agrégation pathologique de protéines/métabolisme , Isoformes de protéines/métabolisme , Analyse spectrale/méthodes , Protéines tau/composition chimique , Protéines tau/isolement et purificationRÉSUMÉ
Efficient purification is crucial to providing large quantities of recombinant therapeutic proteins, such as monoclonal antibodies and cytokines. However, affinity techniques for manufacturing protein therapeutics that use biomolecule-conjugated agarose beads that harness specific biomolecular interactions suffer from issues related to protein denaturation, contamination and the need to maintain biomolecule-specific conditions for efficient protein capture. Here, we report a versatile and scalable method for the purification of recombinant protein therapeutics. The method exploits the high-affinity and controllable host-guest interactions between cucurbit[7]uril (CB[7]) and selected guests such as adamantylammonium. We show that the Herceptin (the brand name of trastuzumab, a monoclonal antibody drug used to treat breast cancer) and the much smaller cytokine interferon α-2a can be purified by site-specifically tagging them with adamantylammonium using the enzyme sortase A, followed by high-affinity binding with CB[7]-conjugated agarose beads and the recovery of the protein using a guest with a stronger affinity for CB[7]. The thermal and chemical stability of CB[7] beads and their scalability, recyclability and low cost may also make them advantageous for the manufacturing of biosimilars.
Sujet(s)
Chromatographie sur agarose/méthodes , Interféron alpha-2/composition chimique , Interféron alpha-2/isolement et purification , Trastuzumab/composition chimique , Trastuzumab/isolement et purification , Composés pontés/composition chimique , Humains , Imidazoles/composition chimiqueRÉSUMÉ
Native and recombinant collectins are purified by using mannan-agarose and an anti-collectin antibody column. The use of sandwich enzyme-linked immunosorbent assay (ELISA) with two antibodies against human mannan-binding lectin (MBL) enables elucidation of the collectin concentration in the blood, serum, and plasma. The collectin sugar specificity is demonstrated by determining the concentration of saccharide required to inhibit sugar binding by 50% in a saccharide-binding assay. Biological analyses including the complement-dependent hemolysis test and several other methods are used to evaluate collectin.
Sujet(s)
Glycoprotéine hémagglutinine du virus influenza/métabolisme , Virus de la grippe A/effets des médicaments et des substances chimiques , Lectine liant le mannose/isolement et purification , Lectine liant le mannose/pharmacologie , Animaux , Poulets , Chromatographie sur agarose , Chiens , Test ELISA , Hémolyse , Humains , Cellules rénales canines Madin-Darby , Mannanes/métabolisme , Lectine liant le mannose/sangRÉSUMÉ
Cyclotides are naturally occurring microproteins (≈30 residues long) present in several families of plants. All cyclotides share a unique head-to-tail circular knotted topology containing three disulfide bridges forming a cystine knot topology. Cyclotides possess high stability to chemical, physical, and biological degradation and have been reported to cross cellular membranes. In addition, naturally occurring and engineered cyclotides have shown to possess various pharmacologically relevant activities. These unique features make the cyclotide scaffold an excellent tool for the design of novel peptide-based therapeutics by using molecular evolution and/or peptide epitope grafting techniques. In this chapter, we provide protocols to recombinantly produce a natively folded cyclotide making use of a standard bacterial expression system in combination with an intein-mediated backbone cyclization with concomitant oxidative folding.
Sujet(s)
Clonage moléculaire/méthodes , Cyclotides/biosynthèse , Ingénierie des protéines/méthodes , Protéines de fusion recombinantes/biosynthèse , Chromatographie d'affinité/méthodes , Chromatographie sur agarose/méthodes , Chromatographie en phase liquide à haute performance , Cyclisation , Cyclotides/composition chimique , Cyclotides/génétique , Cyclotides/isolement et purification , Cystine/composition chimique , Motifs de knottins , Disulfures/composition chimique , Disulfures/métabolisme , Électrophorèse sur gel de polyacrylamide , Escherichia coli/génétique , Intéines , Protéines végétales/biosynthèse , Protéines végétales/composition chimique , Protéines végétales/isolement et purification , Pliage des protéines , Maturation post-traductionnelle des protéines , Protéines de fusion recombinantes/composition chimique , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/isolement et purificationRÉSUMÉ
Lipoprotein lipase (LPL), the enzyme that hydrolyzes triglycerides in plasma lipoproteins, is assumed to be active only as a homodimer. In support of this idea, several groups have reported that the size of LPL, as measured by density gradient ultracentrifugation, is â¼110 kDa, twice the size of LPL monomers (â¼55 kDa). Of note, however, in those studies the LPL had been incubated with heparin, a polyanionic substance that binds and stabilizes LPL. Here we revisited the assumption that LPL is active only as a homodimer. When freshly secreted human LPL (or purified preparations of LPL) was subjected to density gradient ultracentrifugation (in the absence of heparin), LPL mass and activity peaks exhibited the size expected of monomers (near the 66-kDa albumin standard). GPIHBP1-bound LPL also exhibited the size expected for a monomer. In the presence of heparin, LPL size increased, overlapping with a 97.2-kDa standard. We also used density gradient ultracentrifugation to characterize the LPL within the high-salt and low-salt peaks from a heparin-Sepharose column. The catalytically active LPL within the high-salt peak exhibited the size of monomers, whereas most of the inactive LPL in the low-salt peak was at the bottom of the tube (in aggregates). Consistent with those findings, the LPL in the low-salt peak, but not that in the high-salt peak, was easily detectable with single mAb sandwich ELISAs, in which LPL is captured and detected with the same antibody. We conclude that catalytically active LPL can exist in a monomeric state.
Sujet(s)
Lipoprotein lipase/composition chimique , Lipoprotein lipase/isolement et purification , Animaux , Cellules CHO , Bovins , Centrifugation en gradient de densité/méthodes , Chromatographie d'affinité , Chromatographie sur agarose , Cricetulus , Épitopes , Héparine , Humains , Lipoprotein lipase/sang , Récepteurs aux lipoprotéines/sang , Récepteurs aux lipoprotéines/composition chimique , Récepteurs aux lipoprotéines/isolement et purification , Agarose/analogues et dérivés , Triglycéride/métabolisme , UltracentrifugationRÉSUMÉ
In the current study, a dimeric phenoloxidase (PO) from the hemolymph of healthy and diseased (pebrine infected) larvae of Antheraea assamensis Helfer was extracted and purified. The protein was subjected to purification using Sephacryl S-100 and CM Sepharose chromatography. The enzyme comprised of two subunits of ~76.8 and 76 kDa that showed PO activity in 6 mM l-3,4-dihydroxyphenylalanine (L-DOPA) and 8 mM catechol but not in hydroquinone. Optimum temperature for PO activity was 30°C in l-DOPA and 37°C in catechol. Optimum pH ranged from 6.8 to 7.0 in L-DOPA and 7.0-7.2 in catechol. Specific activity of the purified PO from healthy larvae was 53.9 µM/min per mg of protein per ml in L-DOPA and 50.77 µM/min per mg of protein per ml in catechol. Specific activity of PO from diseased larvae was 30.0 µM/min per mg of protein per ml in L-DOPA and 28.55 µM/min per mg of protein per ml in catechol. Purification fold was 3.27-4.21 for healthy and 2.38-2.56 for diseased fractions. The enzyme showed the Michaelis constant (Km ) of 2.46-2.85 mM for healthy and diseased fractions in L-DOPA. In catechol Km of 9.23-17.71 mM was observed. Peptidoglycan was the best activator of purified PO from both healthy and diseased fractions. Interactions between controls and activators appeared statistically significant (F = 767.5; df = 3; P < 0.0001). Na+ , K+ , and Cu2+ increased, whereas Ca2+ , Zn2+ , Mg2+ , and Co2+ decreased PO activity. The overall interactions appeared highly significant (F = 217.0; df = 27; P < 0.0001). Kojic acid, dithiothreitol, thiourea, phenylthiourea, carbendazim, N-bromosuccinimide, N,N,N',N'-tetraacetic acid, and diethyldithiocarbamate inhibited PO activity.
Sujet(s)
Protéines d'insecte/composition chimique , Monophenol monooxygenase/composition chimique , Papillons de nuit/enzymologie , Animaux , Chromatographie sur agarose , Larve/enzymologie , Larve/croissance et développement , Papillons de nuit/croissance et développementRÉSUMÉ
The behavior of human immunoglobulin G (IgG) and antigen-binding fragment (Fab fragment) adsorption onto phospho-l-tyrosine immobilized on agarose (P-Tyr-agarose) was evaluated by pseudoaffinity chromatography. The effects of buffer systems MES, MOPS, Bis-Tris, Tris-HCl and sodium phosphate (NaP) and pH on IgG adsorption were studied and high purity values were obtained (96%, based on ELISA analysis of albumin, transferrin and immunoglobulins A, G and M) when IgG was purified from human plasma diluted in 10 mmol L-1 NaP buffer at pH 6.0. The capture of IgG by the P-Tyr-agarose was also promising, since 91% of the IgG was adsorbed when plasma was diluted in 25 mmol L-1 MES buffer at pH 5.5, recommending its use for IgG depletion from human plasma under this condition. The experimental data on IgG adsorption kinetics were in agreement with the pseudo-second-order model. The adsorption isotherm data were well described by the Langmuir-Freundlich model with the value of parameter n being <1 (0.72), indicating negative cooperativity. Selectivity was achieved on P-Tyr-agarose from digested human IgG in HEPES 25 mmol L-1 buffer at pH 7.0 where Fab fragments were obtained in eluted fractions without Fc fragments (but with uncleaved IgG) with 86.2% recovery.
Sujet(s)
Chromatographie d'affinité/méthodes , Chromatographie sur agarose/méthodes , Fragments Fab d'immunoglobuline/isolement et purification , Immunoglobuline G/isolement et purification , Phosphotyrosine/composition chimique , Adsorption , Humains , Fragments Fab d'immunoglobuline/composition chimique , Fragments Fab d'immunoglobuline/métabolisme , Immunoglobuline G/composition chimique , Immunoglobuline G/métabolisme , Papaïne/métabolismeRÉSUMÉ
A highly selective procedure to extract thiol-containing peptides (TCPs) from complicated soy glycinin hydrolysates (SGHs) was described. This procedure included the reduction of disulfide bonds by 1,4-dithiothreitol (DTT) and enrichment of TCPs through Thiopropyl-Sephrose 6B covalent chromatography. TCPs were confirmed using a strategy based on mass shift after differential alkylation of sulfhydryl groups with iodoacetamide and N-ethylmaleimide by matrix-assisted laser desorption ionization mass spectrometry (MALDI-TOF-MS). The antioxidant activities of TCPs were evaluated using chemical assays. DTT reduction increased the concentration of sulfhydryl groups from 1.8 µmol/g to 113.8 µmol/g. The efficiency of the extraction was improved by optimizing the loading of sample, extraction and desorption time and the content of desorption reagent. Both of the adsorption and desorption process were found to fit a pseudo-second order model. MALDI-TOF-MS showed that 36 of the 45 extracted peptides were TCPs. The EC50 of TCPs for DPPH, hydroxyl radical, and superoxide anion radical was 0.1, 1.49 and 0.084 mg/mL, respectively. The reducing power of TCPs (0.2 mg/mL) was of 0.375. These results suggest that the combination of DTT reduction and Thiopropyl-Sepharose 6B covalent chromatograph was a successful pathway to extract TCPs from SGHs and the TCPs could be used as potential antioxidants.
Sujet(s)
Antioxydants/isolement et purification , Globulines/composition chimique , Glycine max/composition chimique , Peptides/isolement et purification , Hydrolysats de protéines/composition chimique , Protéines de soja/composition chimique , Thiols/composition chimique , Antioxydants/composition chimique , Dérivés du biphényle/antagonistes et inhibiteurs , Chromatographie sur agarose/méthodes , Dithiothréitol/composition chimique , N-Éthyl-maléimide/composition chimique , Radical hydroxyle/antagonistes et inhibiteurs , 2-Iodo-acétamide/composition chimique , Peptides/composition chimique , Picrates/antagonistes et inhibiteurs , Spectrométrie de masse MALDI , Superoxydes/antagonistes et inhibiteursRÉSUMÉ
Liquid biopsy of cancers is an area of increasing interest in medical practice for the surveillance, management, and potential detection of malignant cells, using minimally invasive collection of body fluids. A liquid biopsy is particularly useful for metastatic cancers, which may be difficult to be sampled by core biopsy, due to difficulty of access or an occult location. Access to DNA shed from esophageal adenocarcinoma can enable the detection of mutations confirming the presence of malignant cells or the evolution of clonal lines with altered treatment response profiles. In this chapter, we detail a method for the isolation of cell-free DNA from blood plasma and DNA associated with exosomes in blood from patients with esophageal adenocarcinoma.
Sujet(s)
Adénocarcinome/anatomopathologie , Marqueurs biologiques tumoraux/isolement et purification , ADN tumoral circulant/isolement et purification , Tumeurs de l'oesophage/anatomopathologie , Exosomes/anatomopathologie , Adénocarcinome/sang , Adénocarcinome/génétique , Marqueurs biologiques tumoraux/sang , Chromatographie sur agarose/instrumentation , Chromatographie sur agarose/méthodes , ADN tumoral circulant/sang , Analyse de mutations d'ADN/instrumentation , Analyse de mutations d'ADN/méthodes , Tumeurs de l'oesophage/sang , Tumeurs de l'oesophage/génétique , Exosomes/génétique , Humains , Biopsie liquide/instrumentation , Biopsie liquide/méthodes , MutationRÉSUMÉ
In order to simplify a complex mixture of soluble proteins from tissues, a protocol to fractionate samples prior to two-dimensional (2D) gel electrophoresis has been developed. These methods involve the use of DEAE-Sepharose, SP-Sepharose, and phenyl Sepharose chromatographic columns and the fractionation of the protein mixtures based on differential anionic, cationic, and hydrophobic properties of the proteins, respectively. Fractionation of the soluble proteins with DEAE-Sepharose can result in an increase in the number of detectable 2D gel spots. These gel spots are amenable to protein identification by using in-gel trypsin digestions, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and peptide mass fingerprinting. The DEAE-Sepharose column fractionation acts to partition soluble proteins from cell extracts. Similarly, a SP-Sepharose column can fractionate soluble proteins and increase the number of detectable gel spots. Lastly, fractionation of cell extract with a phenyl Sepharose column can also result in an increase in the number of detectable 2D gel spots. This chapter describes an easy, inexpensive way to fractionate soluble proteins and a way to better profile proteomes.
Sujet(s)
Chromatographie sur agarose/méthodes , Électrophorèse bidimensionnelle sur gel/méthodes , Protéome/analyse , Protéomique/méthodes , Agarose/analogues et dérivés , Spectrométrie de masse MALDI/méthodes , Animaux , Fractionnement chimique/méthodes , Précipitation chimique , Électrophorèse sur gel de polyacrylamide/méthodes , Humains , Cartographie peptidique/méthodes , Protéines/analyse , Protéines/isolement et purification , Protéome/isolement et purification , Agarose/composition chimique , SolubilitéRÉSUMÉ
Interferon lambda-3 (IFNλ3) which is also known as IL28B is a member of type III Interferons which are structurally and genetically different from type I Interferons. These Interferons induce signal transduction pathways similar to type I Interferons which results in the activation of Interferon Stimulated Genes (ISGs). This group of Interferons are tissue specific and reported to have antiviral activity. In the present communication, we report the expression of bovine IFNλ3 gene (coding for the mature protein) in Pichia pastoris, purification of the expressed protein and evaluation of its biological activity. About 19â¯kDa protein expressed by the transformed Pichia cells, secreted into the media and the protein was purified by SP-Sepharose ion exchange chromatography with NaCl stepwise gradient elution. Specificity of the protein was confirmed by Western blotting. Pichia expressed IFNλ3 was found to be biologically active, as it induced ISGs (Mx protein, OAS and PKR genes) in bovine PBMCs. Further it was also found to modulate Th1/Th2 cytokines expression in the stimulated bovine PBMCs.
Sujet(s)
Clonage moléculaire , Interférons/génétique , Agranulocytes , Animaux , Bovins , Chromatographie sur agarose , Expression des gènes , Interférons/isolement et purification , Interleukines/génétique , Interleukines/isolement et purification , Pichia/génétique , Protéines recombinantes/isolement et purification , Interféron lambdaRÉSUMÉ
Heparin, a member of the glycosaminoglycan family, is known to interact with more than 400 different types of proteins. For the past few decades, significant progress has been made to understand the molecular details involved in heparin-protein interactions. Based on the structural knowledge available from the FGF1-heparin interaction studies, we have designed a novel heparin-binding peptide (HBP) affinity tag that can be used for the simple, efficient, and cost-effective purification of recombinant proteins of interest. HBP-tagged fusion proteins can be purified by heparin Sepharose affinity chromatography using a simple sodium chloride gradient to elute the bound fusion protein. In addition, owing to the high density of positive charges on the HBP tag, recombinant target proteins are preferably expressed in their soluble forms. The purification of HBP-fusion proteins can also be achieved in the presence of chemical denaturants, including urea. Additionally, polyclonal antibodies raised against the affinity tag can be used to detect HBP-fused target proteins with high sensitivity. © 2017 by John Wiley & Sons, Inc.
Sujet(s)
Peptides antimicrobiens cationiques/génétique , Protéines du sang/génétique , Protéines de transport/génétique , Chromatographie d'affinité/méthodes , Escherichia coli/génétique , Protéines de fusion recombinantes/isolement et purification , Agarose/analogues et dérivés , Séquence d'acides aminés , Peptides antimicrobiens cationiques/métabolisme , Protéines du sang/métabolisme , Protéines de transport/métabolisme , Chromatographie sur agarose , Clonage moléculaire , Escherichia coli/métabolisme , Expression des gènes , Vecteurs génétiques/composition chimique , Vecteurs génétiques/métabolisme , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/métabolisme , Agarose/composition chimique , Chlorure de sodium/composition chimiqueRÉSUMÉ
The overwhelming majority of influenza vaccines are prepared with the use of chicken embryo allantoic fluid. The presence of ovalbumin (this protein constitutes >60% total protein in the allantoic fluid) in the vaccine can lead to severe allergy. Hence, effective reduction of ovalbumin content is of crucial importance for vaccine production. We compared two methods of purification and concentration of influenza virus: zonal gradient ultracentrifugation and combined ultrafiltration/diafiltration and exclusion chromatography protocol, used for fabrication of seasonal vaccines. Combined chromatography is comparable with zonal centrifugation protocol by the results of ovalbumin removal (to meet standard requirements).
Sujet(s)
Chromatographie sur agarose/méthodes , Vaccins antigrippaux/isolement et purification , Ovalbumine/isolement et purification , Ultracentrifugation/méthodes , Ultrafiltration/méthodes , Liquide amniotique/composition chimique , Liquide amniotique/virologie , Animaux , Embryon de poulet , Humains , Sous-type H1N1 du virus de la grippe A/croissance et développement , Sous-type H1N1 du virus de la grippe A/immunologie , Vaccins antigrippaux/biosynthèse , Grippe humaine/immunologie , Grippe humaine/prévention et contrôle , Grippe humaine/virologieRÉSUMÉ
Background. Candida auris is unique due to its multidrug resistance and misidentification as Candida haemulonii by commercial systems. Its correct identification is important to avoid inappropriate treatments. Aims. To develop a cheap method for differentiating C. auris from isolates identified as C. haemulonii by VITEK2. Methods. Fifteen C. auris isolates, six isolates each of C. haemulonii and Candida duobushaemulonii, and one isolate of Candida haemulonii var. vulnera were tested using CHROMagar Candida medium supplemented with Pal's agar for better differentiation. Results. On CHROMagar Candida medium supplemented with Pal's agar all C. auris strains showed confluent growth of white to cream colored smooth colonies at 37°C and 42°C after 24 and 48h incubation and did not produce pseudohyphae. The isolates of the C. haemulonii complex, on the contrary, showed poor growth of smooth, light-pink colonies at 24h while at 48h the growth was semiconfluent with the production of pseudohyphae. C. haemulonii complex failed to grow at 42°C. Conclusions. We report a rapid and cheap method using CHROMagar Candida medium supplemented with Pal's agar for differentiating C. auris from isolates identified as C. haemulonii by VITEK2 (AU)
Antecedentes. Candida auris es una especie única debido a su resistencia a múltiples fármacos y a la identificación errónea por sistemas comerciales como Candida haemulonii. Su correcta identificación es importante para evitar un tratamiento inadecuado. Objetivos. Desarrollar un método de bajo coste para diferenciar C. auris de aislamientos identificados como C. haemulonii por el método VITEK®2. Métodos. Quince aislamientos de C. auris, seis de C. haemulonii, seis aislamientos de Candida duobushaemulonii y un aislamiento de Candida haemulonii var. vulnera se sembraron en medio CHROMagar Candida enriquecido con medio de Pal para una mejor diferenciación. Resultados. En el medio CHROMagar Candida enriquecido con medio de Pal, todos los aislamientos de C. auris presentaron un crecimiento confluente con colonias lisas de color blanco a blanco amarillento a 37 y 42°C tras 24 y 48 h de incubación; no hubo producción de seudohifas. Los aislamientos del complejo C. haemulonii, en cambio, mostraron un crecimiento menor. Las colonias eran lisas y de un color rosa claro a las 24 h; a las 48 h el crecimiento fue semiconfluente y se observó producción de seudohifas. No hubo crecimiento de ninguno de los aislamientos a 42°C. Conclusiones. El medio CHROMagar Candida enriquecido con medio de Pal es rápido y de bajo coste, y resulta efectivo para identificar C. auris entre cepas previamente identificadas como C. haemulonii por el método VITEK®2 (AU)
Sujet(s)
Humains , Candida/isolement et purification , Candidose/microbiologie , Chromatographie sur agarose/méthodes , Tests de sensibilité microbienne , Techniques de typage mycologique/méthodesRÉSUMÉ
No disponible